TY  - GEN
AU  - Sugimoto,Toshitsugu
AU  - Shiraki,Masataka
AU  - Nakano,Tetsuo
AU  - Kishimoto,Hideaki
AU  - Ito,Masako
AU  - Fukunaga,Masao
AU  - Hagino,Hiroshi
AU  - Sone,Teruki
AU  - Kuroda,Tatsuhiko
AU  - Nakamura,Toshitaka
TI  - Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial
SN  - 1473-4877
PY  - 2013///0809
KW  - Aged
KW  - Aged, 80 and over
KW  - Bone Density
KW  - drug effects
KW  - Bone Density Conservation Agents
KW  - administration & dosage
KW  - Calcium
KW  - Dietary Supplements
KW  - Diphosphonates
KW  - therapeutic use
KW  - Female
KW  - Follow-Up Studies
KW  - Fractures, Bone
KW  - prevention & control
KW  - Hip
KW  - physiology
KW  - Humans
KW  - Male
KW  - Osteoporosis
KW  - drug therapy
KW  - Placebos
KW  - Risk
KW  - Spinal Fractures
KW  - Spinal Injuries
KW  - Spine
KW  - Teriparatide
KW  - Vitamin D
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1185/03007995.2012.761956
ER  -